Cognitive impairment in people with COPD or heart failure - effect of one session of exercise training
Not Applicable
Completed
- Conditions
- COPDCognitive impairmentHeart FailureNeurological - Other neurological disordersRespiratory - Chronic obstructive pulmonary diseaseCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12618000327280
- Lead Sponsor
- Royal Prince Alfred Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
Diagnosis of COPD or heart failure
Exclusion Criteria
Neurological or musculo skeletal problems - so unable to perform treadmill walking or stationary cycling.
Diagnosis of dementia
Inability to read and/or understand the MoCa questionnaire
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Montreal Cognitive Assessment Tool (MoCa) is a questionnaire used to assess cognitive function (thinking and memory). MoCa Version 7.1 will be used at baseline (T1) before 20 minutes of treadmill walking or cycling and MoCa Version 7.2 will be used after the treadmill walking or cycling (T2).<br>[T1 = baseline<br>T2 = end of 20 minutes of exercise]
- Secondary Outcome Measures
Name Time Method Heart rate will be measured using a finger probe connected to a portable oximeter [Every 5 minutes during treadmill walking];Oxygen saturation will be measured using a finger probe connected to a portable oximeter [Every 5 minutes during treadmill walking or cycling<br>]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link exercise to cognitive improvement in COPD and heart failure patients?
How does acute exercise intervention compare to standard care in managing cognitive impairment in COPD and heart failure?
Are there specific biomarkers that predict cognitive response to single-session exercise in COPD or heart failure populations?
What adverse events are associated with acute exercise training in patients with COPD or heart failure and how are they managed?
What combination therapies with exercise show promise in treating cognitive impairment in chronic respiratory and cardiovascular diseases?